Angela N. Brooks, Ph.D.

Affiliations: 
2011 Molecular & Cell Biology University of California, Berkeley, Berkeley, CA, United States 
Google:
"Angela Brooks"
Mean distance: 22.75
 

Parents

Sign in to add mentor
Donald C. Rio grad student 2011 UC Berkeley
 (RNA Splicing Regulation in Drosophila melanogaster .)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Durham M, Vadde S, Brooks AN. (2023) exon 14 skipping is overexpressed in an allele-specific manner in lung adenocarcinoma primary samples. Micropublication Biology. 2023
Pardo-Palacios FJ, Wang D, Reese F, et al. (2023) Systematic assessment of long-read RNA-seq methods for transcript identification and quantification. Biorxiv : the Preprint Server For Biology
Soulette CM, Hrabeta-Robinson E, Arevalo C, et al. (2023) Full-length transcript alterations in human bronchial epithelial cells with S34F mutations. Life Science Alliance. 6
Tang AD, Hrabeta-Robinson E, Volden R, et al. (2023) Detecting haplotype-specific transcript variation in long reads with FLAIR2. Biorxiv : the Preprint Server For Biology
Calabrese C, Davidson NR, Demircioğlu D, et al. (2023) Author Correction: Genomic basis for RNA alterations in cancer. Nature
Thornton AM, Tumu M, Brooks AN. (2022) An expression-based variant impact phenotyping protocol to predict the impact of gene variants in cell lines. Star Protocols. 3: 101651
Reggiardo RE, Maroli SV, Halasz H, et al. (2022) Mutant KRAS regulates transposable element RNA and innate immunity via KRAB zinc-finger genes. Cell Reports. 40: 111104
Thornton AM, Fang L, Lo A, et al. (2021) eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants. Plos Computational Biology. 17: e1009132
Goldman MJ, Craft B, Hastie M, et al. (2020) Visualizing and interpreting cancer genomics data via the Xena platform. Nature Biotechnology
Huang HH, Ferguson ID, Thornton AM, et al. (2020) Proteasome inhibitor-induced modulation reveals the spliceosome as a specific therapeutic vulnerability in multiple myeloma. Nature Communications. 11: 1931
See more...